S & Co »

Blueprint Medicines shares owned by S & Co

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by S & Co from 13F filings

Historical chart of S & Co investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by S & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by S & Co

Quarter filed Position value Share count Share price at filing
2024-06-30 $722k 6.7k 107.76
2024-03-31 $635k 6.7k 94.78

More positions owned by S & Co

Exxon Mobil Corporation (XOM)
Church & Dwight (CHD)
Microsoft Corporation (MSFT)
Berkshire Hathaway (BRK.B)
Apple (AAPL)
Ecolab (ECL)
Merck & Co (MRK)
Automatic Data Processing (ADP)
Caterpillar (CAT)
Mosaic (MOS)
Alphabet Inc Class C cs (GOOG)
Cameco Corporation (CCJ)
Abbott Laboratories (ABT)
Amazon (AMZN)
Johnson & Johnson (JNJ)

View all positions for S & Co

Top funds holding Blueprint Medicines

BlackRock
Vanguard Group
T. Rowe Price Associates
FMR
Wellington Management Company
Rock Springs Capital Management
State Street Corporation
Pictet Asset Management Holding SA
William Blair Investment Management
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Lord, Abbett & Co
Alliancebernstein
Holocene Advisors

View all funds holding Blueprint Medicines